LNSR — LENSAR, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1320350 ·
Last close
$6.92
Market Cap
$85.02M
52W High
$12.94
52W Low
$4.95
ADV30
98,840
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 16,495,000 | 9,776,000 | 2,134,000 | 3,535,000 | 69,558,000 | 13,565,000 | 54,653,000 |
| Mar 2026 | 13,428,000 | 6,382,000 | 2,239,000 | 36,332,000 | 66,223,000 | 12,494,000 | 55,433,000 |
| Dec 2025 | 16,025,000 | 6,937,000 | -4,919,000 | -1,458,000 | 71,430,000 | 12,974,000 | 97,449,000 |
| Sep 2025 | 14,316,000 | 6,036,000 | -7,580,000 | -3,713,000 | 70,204,000 | 7,637,000 | 96,111,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-12,164,000
Investing CF
$4,753,000
Financing CF
$358,000
CapEx
$-86,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.58
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-141,243,000
Inventory
$23,099,000
Receivables
$5,183,000
ST Investments
$1,001,000
EBIT TTM
$-16,549,000
Pretax Income TTM
$29,397,000
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$60,264,000
EBITDA
$-16,328,000
Free Cash Flow
$-24,391,250
Enterprise Value
$95,972,576
Total Cash
$13,565,000
Total Debt
$2,381,000
Shares Out
12,285,865
Trailing EPS
$0.20
Book Value
$1.21
ROE
357.3%
ROA
-18.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 58,435,000 | -24,578,000 | -34,280,000 | 71,430,000 | 97,449,000 | -26,019,000 | -14,831,000 |
| Dec 2024 | 53,494,000 | -6,936,000 | -31,404,000 | 66,297,000 | 61,435,000 | 4,862,000 | -2,275,000 |
| Dec 2023 | 42,164,000 | -12,229,000 | -14,383,000 | 69,585,000 | 36,156,000 | 33,429,000 | -9,659,000 |
| Dec 2022 | 35,358,000 | -20,177,000 | -19,914,000 | 55,844,000 | 13,860,000 | 41,984,000 | -14,856,000 |
TTM Snapshot
Revenues TTM
$12,636,000
NetIncome TTM
$-9,043,000
OpCashFlow TTM
$0
Assets (Latest)
$66,297,000
Forward EPS
$-0.71
Max Pain — expiry 2026-10-16
max pain strike: $7.50 · spot: $6.82 · call oi: 3,333 · put oi: 566
Expected Move to 2026-10-16:
±$0.98
(14.30%) —
implied range
$5.85 –
$7.80
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MBOT | Microbot Medical Inc. | $85.97M | $1.28 | — |
| SKIN | SkinHealth Systems Inc. | $86.54M | $0.67 | — |
| LUNG | Pulmonx Corp | $82.03M | $1.91 | — |
| STEX | Streamex Corp. | $81.53M | $0.70 | — |
| GUTS | FRACTYL HEALTH, INC. | $77.36M | $0.49 | — |
News headlines (Yahoo Finance, 1h cache)
LENSAR (LNSR) Q2 2026 Earnings Call Transcript
2026-08-20 14:13 · Yahoo
LENSAR Inc (LNSR) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge
2026-08-13 23:07 · Yahoo
LENSAR Q2 Earnings Call Highlights
2026-08-13 17:04 · Yahoo
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
2026-08-13 11:00 · Yahoo
LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026
2026-08-06 12:00 · Yahoo
Lensar (LNSR) Q1 2026 Earnings Transcript
2026-06-01 17:10 · Yahoo
Lensar (LNSR) Q4 2025 Earnings Transcript
2026-06-01 17:10 · Yahoo
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
2026-05-08 11:00 · Yahoo
LENSAR® to Report First Quarter 2026 Results on May 8, 2026
2026-04-30 11:00 · Yahoo
How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential
2026-04-21 05:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.